18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: A multicentre study

European Journal of Radiology

Volumn 80, Issue 3, 2011, Pages 828-833

  Grassetto, Gaia ^a   Fornasiero, Adriano ^b   Otello, Daniele ^b   Bonciarelli, Giorgio ^c   Rossi, Elena ^d   Nashimben, Ottorino ^e   Minicozzi, Anna Maria ^f   Crepaldi, Giorgio ^a   Pasini, Felice ^a   Facci, Enzo ^g   Mandoliti, Giovanni ^a   Marzola, Maria Cristina ^a   Al Nahhas, Adil ^h   Rubello, Domenico ^a  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Este Monselice Hospital   (Italy)

^d Chioggia Civil Hospital   (Italy)

^e Oncologic Unit   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

^g San Luca Hospital   (Italy)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

18F FDG PET CT; Breast cancer; Ca 15 3; Negative conventional imaging; Recurrence

Indexed keywords

CA 15-3 ANTIGEN; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER; DIAGNOSTIC AGENT; MUCIN 1; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER STAGING; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX WALL; BLOOD; BREAST TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ITALY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; ITALY; MIDDLE AGED; MUCIN-1; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 80755148777     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.04.029     Document Type: Article

References (39)

1. C. Lohrisch, and M. Piccart Carcinoma della mammella R.E. Pollock, J.H. Doroshok, D. Khayat, A. Nakao, B. O'Sullivan, "UICC manuale di oncologia clinica" Minerva Medica VIII ed. 2008 530 565
2. W. Siggelkow, W. Rath, U. Buell, and M. Zimny FDG PET and tumor markers in the diagnosis of recurrent and metastatic breast cancer Eur J Nucl Med Mol Imaging 31 Suppl. 1 2004 S118 S124
3. N. Avril, C.A. Rose, and M. Schelling Breast imaging with positrone emission tomography and fluorine-18 fluorodeoxyglucose: use and limitation J Clin Oncol 18 2000 3495 3502
4. D.N. Danforth Jr., L. Aloj, and J.A. Carrasquillo The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer Breast Cancer Res Treat 75 2002 135 146 (Pubitemid 34994949)
5. J.A. van Dongen, A.C. Voogd, and I.S. Fentiman Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial J Natl Cancer Inst 19 2000 1143 1150
6. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trial. From the breast cancer cooperative group of the European organization for research and treatment of cancer J Clin Oncol 19 2001 1688 1697 (Pubitemid 32230869)
7. E.M. Kamel, M.T. Wyss, M.K. Fehr, G.K. von Schulthess, and G.W. Goerres 18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer J Cancer Res Clin Oncol 129 2003 147 153 (Pubitemid 36583695)
8. A. Fortin, M. Larochelle, J. Lverdiere, S. Lavertu, and D. Tremblay Local failure is responsible for decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy J Clin Oncol 17 1999 101 109 (Pubitemid 29022383)
9. L. Radan, S. Ben-Haim, R. Bar-Shalom, L. Guralnik, and O. Israel The role of FDG-PET/CT in suspected recurrence of breast cancer Cancer 107-111 2001 2545 2551
10. J. Khatcheressian, and T.J. Smith Symptom-oriented follow-up of early breast cancer - as good as conventional control and sparing resources Onkologie 30 2007 410 412 (Pubitemid 350194936)
11. J. Khatcheressian, A.C. Wolff, and T.J. Smith The American society of clinical oncology breast cancer surveillance expert panel. ASCO 2006. Update of the breast cancer follow-up and management guideline in the adjuvant setting J Oncol Pract 2 2006 317 318
12. E. Grunfeld, D. Mant, and P. Yudkin Routine follow-up for breast cancer in primary care: randomized trial BMJ 13 1996 665 669 (Pubitemid 26300604)
13. P.B. Hathaway, D.A. Mankoff, and K.R. Maravilla Value of combined FDG PET and MRI imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience Radiology 210 1999 807 814 (Pubitemid 29124045)
14. L. Harris, H. Fritsche, and R. Mennel American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 2007 5287 5312 (Pubitemid 350232263)
15. A.R. Haug, G.P. Schmidt, and A. Klingenstein F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers J Comput Assist Tomogr 31 2007 629 634 (Pubitemid 47457683)
16. E. Joseph, M. Hyacinthe, and G.H. Lyman Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer Ann Surg Oncol 5 1998 522 528 (Pubitemid 28421752)
17. T. Nakamura, T. Kimura, and Y. Umehara Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery Surg Today 35 2005 19 21 (Pubitemid 40941124)
18. M. Rojas, E. Telaro, and A. Russo Follow-up strategies for women treated for early breast cancer Cochrane Database Syst Rev 2005 CD001768
19. M. Suarez, M.J. Perez-Castejon, and A. Jimenez Early diagnosis of recurrent brest cancer with FDG-PET in patients with progressive elevation of serum tumor markers Q J Nucl Med 46 2002 113 121
20. A. Ruibal, J. Genolla, M. Rosell, J.M. Gris, and R. Colomer Serum CA 15-3 levels in patients with non-tumoral diseases and establishment of a threshold for a tumoral activity. Results in 1219 patients Int J Biol Markers 3 1986 159 160
21. J. Hilkens, F. Buijs, and J. Hilgers Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors Int J Cancer 34 1984 197 206 (Pubitemid 14053141)
22. L. Mariani, R. Miceli, S. Michilin, and M. Gion Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumor recurrences Biomarkers 14 2 2009 130 136
23. A.P. Pecking, C. Mechelany-Corone, and F. Bertrand-Kermorgant Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography Clin Breast Cancer 2 3 2001 229 234 (Pubitemid 33085771)
24. S. Chourin, C. Veyret, A. Chevrier, A. Loeb, C. Gray, and J. Basuyau Routine use of serial plasmatic CA 15-3 determinations during the follow-up of patients treated for breast cancer. Evaluation as factor of early diagnosis of recurrence Ann Biol Clin 66 4 2008 385 392
25. S. Zervoudis, P. Peitsidis, and G. Iatrakis Increased levels of tumor markers in follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results J Buon 12 4 2007 487 492
26. O. Israel, M. Mor, and L. Guralnik Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? J Nucl Med 45 2004 2045 2051 (Pubitemid 47611634)
27. E.E. Zervos, B.D. Badgwell, W.E. Burak Jr., M.W. Arnold, and E.W. Martin Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup Surgery 130 2001 636 644 (Pubitemid 32964609)
28. H. Jadvar, and A.J. Fischman Evaluation of pancreatic carcinoma with FDG PET Abdom Imaging 26 2001 254 259 (Pubitemid 32428945)
29. T. Torizuka, S. Nobezawa, and Kanno Ovarian cancer recurrence: role for whole-body positron emission tomography using 2-[fluorine-18]-fluoro-deony-d- glucose Eur J Nucl Med 29 2002 797 803
30. T.H.A. Arulampalam, D.C. Costa, M. Loizidou, D. Visvikis, P.J. Ell, and I. Taylor Positron emission tomography and colorectal cancer Br J Surg 88 2001 176 189 (Pubitemid 32142702)
31. G. Buccheri, and D. Ferrigno Serum biomarkers facilitate the recognition of early-stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non small cell lung cancer J Thorac Cardiovasc Surg 122 2001 891 899
32. E.A. Sijmons, and A.P. Heinz Second look and second surgery: second chance or second best? Semin Oncol 19 2000 54 61 (Pubitemid 30439316)
33. L. Esserman Integration of imaging in the management of breast cancer J Clin Oncol 23 2005 1601 1602 (Pubitemid 46211408)
34. R. Bar-Shalom, N. Yefremov, and L. Guralnik The clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 2003 1200 1209 (Pubitemid 39655178)
35. P. Flamen, O.S. Hoekstra, and F. Homans Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET) Eur J Cancer 37 2001 862 869 (Pubitemid 32323964)
36. V. Kalff, R.J. Hicks, R.E. Ware, A. Hogg, D. Binns, and A.F. McKenzie The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study J Nucl Med 43 2002 492 499 (Pubitemid 34286344)
37. H.J. Gallowitsh, E. Kresnik, and J. Gasser F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging Invest Radiol 38 2003 250 256 (Pubitemid 36535030)
38. S. Makhija, N. Howden, R. Edwards, J. Kelley, D.W. Townsend, and C.C. Meltzer Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review Gynecol Oncol 85 2002 53 58 (Pubitemid 34304010)
39. J. Czernin, and M.E. Phelps Positron emission tomography scanning: current and future application Ann Rev Med 53 2002 89 112 (Pubitemid 34177873)